[1]朱羽苑,黄钢.分子核医学显像展望:多参数分子显像时代[J].国际放射医学核医学杂志,2010,34(3):129-134.
　ZHU Yu-yuan,HUANG Gang.The development of nuclear medicine molecular imaging: An era of multiparametric imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):129-134.
点击复制

分子核医学显像展望:多参数分子显像时代(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
34
期数:
2010年第3期
页码:
129-134
栏目:
实验核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The development of nuclear medicine molecular imaging: An era of multiparametric imaging
作者:
朱羽苑;  黄钢
上海交通大学医学院附属仁济医院核医学科, 200127
Author(s):
ZHU Yu-yuan;  HUANG Gang
Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University of Medicine, Shanghai 200127, China
关键词:
分子诊断技术; 多模式影像技术; 正电子发射断层显像术
Keywords:
Molecular diagnostic techniques; Multimodality imaging technology; Positron-emission tomography
分类号:
10.3760/cma.j.issn.1673-4114.2010.03.001
摘要:
核医学分子显像呈多模式、多示踪剂发展趋势,不同显像模式、不同显像示踪剂带来的多参数信息为临床和实验室的研究提供了更丰富的互补信息.其中,PET-MRI将成为核医学分子显像未来发展的一个热门话题.该文着重探讨了核医学分子显像发展过程中,由单模式到多模式、由单示踪剂到多示踪剂的演变过程,总结多模式、多示踪剂、多参数分子显像的定义、区别、优缺点和存在问题,并探讨了分子显像的未来发展.
Abstract:
Nuclear medical molecular imaging is developing toward a multimodality and multitracer future. Abundant complementary data generated from different tracers in different modalities are successfully serving the biological research and clinical treatment. Among the others, PET-MRI has the greatest potential and will be a research of interest in the near future. This article focused on the evolution history of nuclear medicine from single modality to multimodality, single tracer to multitracer. It also gave a brief summary to the identifications, differences, pros and consofmultimodality, multitracer, multiparametric molecular imaging.Issues, problems and challenges concerned with her development and recognition are also discussed.

参考文献/References:

[1] Townsend DW. Positron emission tomographycomputed tomography. Semin Nucl 2006, 38(3):152-166.
[2] Piehler BJ, Wehrl HF, Kolb A, et al Positron emission tomography/magnetic resonance imaging the next generation of multimodality imaging?. Semin Nucl Med, 2008, 38(3):199-208.
[3] Seemann MD. Whole-body PET/MRI:the future in oncological imaging. Technol Cancer Res Treat, 2005, 4(5):577-582.
[4] Ruf J, Lopez Hähming E, Bähmig M, et al. Impact of FDG-PET/MRl image fusion on the detection of pancreatic cancer. Pancreatology, 2006, 6(6):512-519.
[5] Schlemmer HP, Pichler BJ, Krieg R, et al. An integrated MR/PET system:prospective applications. Abdom Imaging, 2009, 34(6):668-674.
[6] Holdsworth SJ, Bammer R. Magnetic resonance imaging techniques, fMRI, DWI, and PWI. Semin Neurol, 2008, 28(4):395-406.
[7] Del Guerra A, Bartoli A, Belcari N, et al Performance evaluation of the fully engineered YAP-(S) PET scanner for small animal imaging. IEEE Trans Nucl Sci, 2006, 53(3):1078-1083.
[8] Douraghy A, Rannou FR, Silverman RW, et al FPGA electronics for OPET:a dual-modality optical and positron emission tomograph. IEEE Trans Nuci Sci, 2008, 55(5):2541-2545.
[9] Gulsen G, Birgul 0, Unlu MB, et al. Combined diffuse optical tomography(DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat, 2006, 5(4):351-363.
[10] Del Guerra A, Belcari N. State-of-the-art of PET, SPECT and GT for small animal imaging. Nucl Instrum Methods Phys Res A, 2007, 583(1):119-124.
[11] Pamham KB, Chowdhury S, Li J, et al. Second-generation, trimodality pre-clinical imaging system//IEEE. Nucl Sci Symposium Conference Record. San Diego:IEEE, 2006:1802-1805.
[12] Peter J, Semmler W, A modular design triple-modality SPECT-CT-ODT small animal imager. Eur J Nucl Med Mol Imaging, 2007, 34(Suppl):S158.
[13] de Jong HW, Beekman FJ, Viergever MA, et al. Simultaneous (99m) Tc/(201) T1 dual-isotope SPET with Monte Carlo-based downscatter correction. Eur J Nucl Med Mol Imaging, 2002, 29(8):1063-1071.
[14] Ouyang J, El Fakhri G, Moore SC. Fast Monte Carlo based joint iterative reconstruction for simultaneous 99mTc/123I SPECT imaging. Med Phys, 2007, 34(8):3263-3272.
[15] Kadrmas DJ, Rust TC. Feasibility of rapid multi-tracer PET tumor imaging. IEEE Trans Nucl Sci, 2005, 52(5):1341-1347.
[16] Rust TC, Kadnnas DJ. Rapid dual-tracer PTSM+ATSM PET imaging of tumour blood flow and hypoxia:a simulation study. Phys Med Biol, 2006, 51(1); 61-75.
[17] Rust TC, DiBella EV, McCann CJ, et al. Rapid dual-injection single-scan 13N-ammonia PET for quantification of rest and stress myocardial blood flows. Phys Med Biol, 2006, 51(20):5347-5362.
[18] Black NF, Kadnnas DJ. Measurement of secondary tracers in FDC tumor imaging by rapid multi-tracer PET//IEEE. Nuclear Science Symposium Conference Record. Honolulu:IEEE, 2007:2825-2832.
[19] Black NF, Mcjames S, Rust TC, et al. Evaluation of rapid dual-tracer (62)Cu-PTSM +(62)Cu-ATSM PET in dogs with spontaneously occurring tumors. Phys Med Biol, 2008, 53(1):217-232.
[20] Verhaeghe J, D’AsseIerY, De Winter O, et al. Simultaneous dual tracer NHi/FDG cardiac PET imaging:a simulation study. J Nucl Med, 2005, 46(SuPPl 1):S56.
[21] El Fakhri G, Sitek A, Guérin B. Simultaneous dual tracer PET using generalized factor analysis of dynamic sequences//IEEE. Nuclear Science Symposium Medical Imaging Conference Record. San Diego:IEEE, 2006:2128-2130.
[22] Basu S. Selecting the optimal image segmentation strategy in the era of multitracer multimodality imaging:a critical step for image-guided radiation therapy. Eur J Nucl Med Mol Imaging, 2009, 36(2):180-181.
[23] Herzog H, Pietrzyk U, Shah NJ, et al. The current state, challenges and perspectives of MR-PET, Neuroimage, 2010, 49(3):2072-2082.
[24] Lecomte R. Novel detector technology for clinical PET. Eur J Nucl Med Mol Imaging, 2(X)9, 36(Suppl 1):S69-S85.
[25] Li X, Lockhart C, Lewellen TK, et al. A high resolution, monolithic crystal, PET/MRI detector with DOI positioning capability//IEEE. 30th Annual International Conference. Vancouver:IKKE. 2008; 2287-2290.
[26] Hofmann M, Pichler B, Schölkopf B, et al. Towards quantitative PEY/MRI:a review of MR-based attenuation correction techniques.Eur J Nucl Med Mol Imaging, 2009,36(Suppl 1):S93-S104.
[27] Kops ER, Herzog H. Alternalive methods for attenuation rorreotion for PET images in MR-PET scanners//IEEE. Nuclear Science Symposium Conference Record. Honolulu; IEEE, 2007:4327-4330.
[28] Hofmann M, Steinke F, ScheelV, et al. MRI-based attenuation correction for PET/MRI:a novelapproach combining pattern rerognition and atlas registration. J Nucl Med, 2008, 49(11):1875-1883.
[29] Brix G, Nekolla EA, Nosske D, et al. Risks and safety aspects related to PET/MR examinations. Eur J Nucl Med Moi Imaging. 2009.36(Suppl 1):S131-S138.
[30] Fullerton GD. TTie development of technologies for molecular imaging should be driven principally by biological questions to be addressed rather than by simply modifying existing imaging technologies. For the preposition. Med Phys, 2005, 32(5):1231-1232.

相似文献/References:

[1]裴之俊,张永学.报告基因显像监测干细胞治疗的研究进展[J].国际放射医学核医学杂志,2010,34(2):73.[doi:10.3760/cma.j.issn.1673-4114.2010.02.002]
　PEI Zhi-jun,ZHANG Yong-xue.Advances of reporter gene imaging monitoring stem cell therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):73.[doi:10.3760/cma.j.issn.1673-4114.2010.02.002]
[2]王金玉,武兆忠.反义寡脱氧核苷酸技术在分子影像中的应用[J].国际放射医学核医学杂志,2009,33(1):1.[doi:10.3760/cma.j.issn.1673-4114.2009.01.001]
　WANG Jin-yu,WU Zhao-zhong.Antisense oligodeoxynucleotides in the application of molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):1.[doi:10.3760/cma.j.issn.1673-4114.2009.01.001]
[3]方圣伟,奚望,张宏.分子核医学的发展和应用前景[J].国际放射医学核医学杂志,2009,33(6):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]
　FANG Sheng-wei,XI Wang,ZHANG Hong.The developments and applications of molecular nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]
[4]常伟,高再荣.甲状腺癌分子影像诊断与靶向治疗研究进展[J].国际放射医学核医学杂志,2009,33(4):218.[doi:10.3760/cma.j.issn.1673-4114.2009.04.008]
　CHANG Wei,GAO Zai-rong.Advances on molecular imaging diagnosis and targeted therapy of thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):218.[doi:10.3760/cma.j.issn.1673-4114.2009.04.008]
[5]张国鹏,张永学.心肌缺血性疾病基因治疗及分子影像监测进展[J].国际放射医学核医学杂志,2008,32(5):257.
　ZHANG Guo-peng,ZHANG Yong-xue.Advances in gene therapy of myocardial ischemia and the monitoring with molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):257.
[6]李天然,田嘉禾.小动物PET及PET-CT及其在分子影像学中的应用[J].国际放射医学核医学杂志,2008,32(1):1.
　LI Tian-ran,TIAN Jia-he.Small animal PET and PET-CT its application in molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):1.
[7]阳艳丽,王自正.噬菌体展示技术在肿瘤诊断和治疗中的应用[J].国际放射医学核医学杂志,2008,32(2):65.
　YANG Yan-li,WANG Zi-zheng.Application of phage display in diagnosis and therapy of cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):65.
[8]黄代娟,张永学.动脉粥样硬化的分子核医学研究进展[J].国际放射医学核医学杂志,2007,31(5):264.
　HUANG Dai-juan,ZHANG Yong-xue.The development of molecular nuclear medicine in atherosclerosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(3):264.
[9]李天然,田嘉禾.功能与分子影像学的内涵与范畴[J].国际放射医学核医学杂志,2007,31(4):193.
　LI Tian-ran,TIAN Jia-he.Connotation and category of functional-molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(3):193.

备注/Memo

备注/Memo:
收稿日期:2010-02-11。
通讯作者:黄钢(E-mail:huang2802@163.com)
更新日期/Last Update: 1900-01-01